Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Post Marketing Survey Study to Evaluate the Safety and Effectiveness of Intelence

This study has been completed.
Information provided by (Responsible Party):
Janssen Korea, Ltd., Korea Identifier:
First received: December 3, 2012
Last updated: March 31, 2016
Last verified: March 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2014
  Primary Completion Date: July 2014 (Final data collection date for primary outcome measure)